Nautilus Biotechnology to announce Q2 2026 results on July 28
Nautilus Biotechnology, Inc. will release its Q2 2026 financial results on July 28, 2026, prior to market open. A conference call is scheduled for 8:30 a.m. ET to discuss the results and business outlook. The webcast will be available on the company's website.

*this image is generated using AI for illustrative purposes only.
Nautilus Biotechnology, Inc. will announce its financial results for the second quarter of 2026 before the market opens on Tuesday, July 28, 2026. The company, which is developing a single-molecule protein analysis platform, scheduled the release to provide investors with an update on its performance and business developments.
Following the announcement, Nautilus’s management will conduct a conference call at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time. The webcast will be accessible live through the "Investors" section of the company’s official website at www.nautilus.bio .
Conference Call Details
The call will cover the quarterly financial outcomes, recent business developments, and the company’s forward-looking outlook. Investors and interested parties can listen to the live audio feed online.
| Event | Date | Time (PT) | Time (ET) |
|---|---|---|---|
| Q2 2026 Results Release | July 28, 2026 | Before Market Open | Before Market Open |
| Conference Call Webcast | July 28, 2026 | 5:30 a.m. | 8:30 a.m. |
Nautilus is a development-stage life sciences company headquartered in Seattle, Washington, with research and development operations in San Carlos, California. Its mission focuses on transforming proteomics by democratizing access to the proteome to enable advancements in human health and medicine.
What key milestones does Nautilus aim to achieve in the second half of 2026?
How might the Q2 results influence investor confidence in Nautilus's protein analysis platform?
What potential partnerships or collaborations could emerge from the business developments discussed?





















